Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer (Q43549877)

24 November 2017

title

Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer (English)

1 reference

24 November 2017

2

1 reference

24 November 2017

1

Karin Milde-Langosch

1 reference

24 November 2017

4

Isabell Witzel

1 reference

24 November 2017

Volkmar Müller

3

1 reference

24 November 2017

Achim Rody

series ordinal

5

1 reference

24 November 2017

Markus Schmidt

series ordinal

6

1 reference

24 November 2017

Ralph M Wirtz

series ordinal

7

1 reference

24 November 2017

language of work or name

English

0 references

publication date

8 November 2012

1 reference

Breast Cancer Research and Treatment

24 November 2017

published in

1 reference

24 November 2017

volume

137

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

57-67

1 reference

24 November 2017

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Measuring proliferation in breast cancer: practicalities and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Proliferation marker Ki-67 in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Ki67 in breast cancer: prognostic and predictive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

The value of TOP2A gene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

MgcRacGAP is involved in cytokinesis through associating with mitotic spindle and midbody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Phosphorylation by Aurora B Converts MgcRacGAP to a RhoGAP during Cytokinesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

A Rac GTPase-activating protein, MgcRacGAP, is a nuclear localizing signal-containing nuclear chaperone in the activation of STAT transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Identification of genes correlated with early-stage bladder cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2296-X

10.1007/S10549-012-2296-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

1023206132

0 references

Fatcat ID

release_3253fy56xbfgtbzrjoikc5myru

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3253fy56xbfgtbzrjoikc5myru

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference